Your Health
Drug name
Registration No.
Indications
Popular experiment questions
Trial stage
Recruitment objects
Test status
CDE publicity platform
BT-114143
injectable
CTR20222910
Treatment and prevention of various bleeding and diseases caused by hyperfibrinolysis
Phase I clinical trial of anti-hyperfibrinolytic drugs
Phase I
Healthy subjects
©2002-2021 ScinnoHub Pharmaceutical Co., Ltd. All rights reserved. Sichuan ICP No. 2021033182-1